Skip to main content
Premium Trial:

Request an Annual Quote

Mosaic Receives $2.0M ATP Grant

NEW YORK, Oct 6 – Mosaic Technologies received a $2.0 million grant from the U.S. Department of Commerce’s Advanced Technology Program to develop its high-throughput gene sequencing system.

One of 54 companies to receive project funding from the ATP, Mosaic Technologies of Waltham, Mass., said its technology has the potential to provide five to 50 million bases of gene sequence information per day on a glass slide.

“This amounts to a 1,000-fold increase in sequencing output,” Chris Boles, the company’s vice president of research, said in a statement.

The model for achieving this goal is based on solid-phase fluorescent in situ sequencing, which does not require electrophoresis. The system is meant for use in conjunction with Mosaic’s Polony microarray technology and Acrydite chemistry platform.

Mosaic did not say when it expects to make the technology available for commercial purposes. But it did note that it hopes the new product will help the company to capture a chunk of the DNA sequencing market, which is expected to grow to over $4 billion in 2004, up from $975 million currently.

Earlier this week, 3 rd Millennium of Cambridge, Mass., announced that it received a $1.8 million grant from the ATP to develop software for handling complex data relationships within genomics.

The Advanced Technology Program is administered by the National Institute of Standards and Technology at the Department of Commerce.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.